BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36269545)

  • 1. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients.
    Pinheiro SL; Maciel J; Cavaco D; Figueiredo AA; Damásio IL; Donato S; Passos J; Simões-Pereira J
    Hormones (Athens); 2023 Mar; 22(1):79-85. PubMed ID: 36269545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
    Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M
    Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
    Cnossen MH; Stam EN; Cooiman LC; Simonsz HJ; Stroink H; Oranje AP; Halley DJ; de Goede-Bolder A; Niermeijer MF; de Muinck Keizer-Schrama SM
    Pediatrics; 1997 Oct; 100(4):667-70. PubMed ID: 9310522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature.
    Kocova M; Kochova E; Sukarova-Angelovska E
    BMC Endocr Disord; 2015 Dec; 15():82. PubMed ID: 26666878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis type 1 and precocious puberty.
    Virdis R; Sigorini M; Laiolo A; Lorenzetti E; Street ME; Villani AR; Donadio A; Pisani F; Terzi C; Garavelli L
    J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():841-4. PubMed ID: 10969931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
    Listernick R; Ferner RE; Liu GT; Gutmann DH
    Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis 1-associated optic pathway gliomas.
    Shofty B; Ben Sira L; Constantini S
    Childs Nerv Syst; 2020 Oct; 36(10):2351-2361. PubMed ID: 32524182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
    Santoro C; Perrotta S; Picariello S; Scilipoti M; Cirillo M; Quaglietta L; Cinalli G; Cioffi D; Di Iorgi N; Maghnie M; Gallizia A; Parpagnoli M; Messa F; De Sanctis L; Vannelli S; Marzuillo P; Miraglia Del Giudice E; Grandone A
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32294191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.
    King A; Listernick R; Charrow J; Piersall L; Gutmann DH
    Am J Med Genet A; 2003 Oct; 122A(2):95-9. PubMed ID: 12955759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and pubertal disorders in neurofibromatosis type 1.
    Virdis R; Street ME; Bandello MA; Tripodi C; Donadio A; Villani AR; Cagozzi L; Garavelli L; Bernasconi S
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():289-92. PubMed ID: 12729406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic pathway glioma and endocrine disorders in patients with and without NF1.
    Gil Margolis M; Yackobovitz-Gavan M; Toledano H; Tenenbaum A; Cohen R; Phillip M; Shalitin S
    Pediatr Res; 2023 Jan; 93(1):233-241. PubMed ID: 35538247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
    J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
    de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA
    J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
    Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
    Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].
    Florent C; Beylerian M; Mairot K; Dambricourt L; André N; David T; Girard N; Audic F; Denis D
    J Fr Ophtalmol; 2022 Feb; 45(2):173-184. PubMed ID: 34972579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C; Aharoni S; Halevy A
    Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.